JOHN FRANK MCLEOD III

Allopathic & Osteopathic Physicians|Family Medicine CHERAW, SC NPI 1154480028

General Payments — all program years on this page

$3,719.17

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 158
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $223.26 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $223.2613

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $278.2019
2019 $1,692.6728
2020 $504.6533
2021 $671.6843
2022 $252.2116
2023 $96.506
2024 $223.2613

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096896751 Novo Nordisk Inc $15.10 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097501360 Novo Nordisk Inc $18.83 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105490243 AstraZeneca Pharmaceuticals LP $24.14 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105607847 AstraZeneca Pharmaceuticals LP $19.37 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105623971 AstraZeneca Pharmaceuticals LP $18.26 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105840707 AstraZeneca Pharmaceuticals LP $15.10 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117894373 Boehringer Ingelheim Pharmaceuticals, Inc. $14.55 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117894375 Boehringer Ingelheim Pharmaceuticals, Inc. $16.35 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124872240 Abbott Laboratories $14.34 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135057844 Lilly USA, LLC $17.10 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144599358 Xeris Pharmaceuticals, Inc. $16.15 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144599360 Xeris Pharmaceuticals, Inc. $15.24 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151095353 Phathom Pharmaceuticals, Inc. $18.73 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.